Floatz logo

1-PIPERAZINEACETIC ACID, 4-(PHENYLMETHYL)-, ((2-HYDROXY-3-(2-PROPENYL)PHENYL)METHYLENE)HYDRAZIDE

Uveal Melanoma

Arkadiusz Z. Dudek, MDSmall moleculePhase 1/2Dormant
C
33/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
18/ 100
Competitive Position
81/ 100

Competitive context

64 Active assets in the Uveal Melanoma cohort.

Asset / SponsorPhaseRating
Ifa
Craig L Slingluff, Jr
Phase 2BBB
Tyrosinase Peptide
University of Southern California
Phase 3BB
Sargramostim
Thomas Jefferson University
Phase 3BB
Cyclophosphamide
Beijing Biotech
Phase 2/3BB
Darovasertib
IDEAYA Biosciences
Phase 3BB

View all 50 →

Same molecule, other indications

1-PIPERAZINEACETIC ACID, 4-(PHENYLMETHYL)-, ((2-HYDROXY-3-(2-PROPENYL)PHENYL)METHYLENE)HYDRAZIDE is also rated in:

pancreatic neuroendocrine tumorDormant
C
Indicative ·
32 / 100
View asset →
neuroendocrine neoplasmDormant
D
Indicative ·
31 / 100
View asset →
glioblastomaDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →